Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma

Abstract Background The solute carrier (SLC) 7 family genes comprise 14 members and function as cationic amino acid/glycoprotein transporters in many cells, they are essential for the maintenance of amino acid nutrition and survival of tumor cells. This study was conducted to analyze the association...

Full description

Bibliographic Details
Main Authors: Lei Shen, Chunhua Qian, Huimin Cao, Zhongrui Wang, Tingxian Luo, Chunli Liang
Format: Article
Language:English
Published: BMC 2018-12-01
Series:World Journal of Surgical Oncology
Subjects:
PTC
Online Access:http://link.springer.com/article/10.1186/s12957-018-1535-y
id doaj-4bf8dcfb4f904e11971e2422388a8646
record_format Article
spelling doaj-4bf8dcfb4f904e11971e2422388a86462020-11-25T02:09:57ZengBMCWorld Journal of Surgical Oncology1477-78192018-12-011611710.1186/s12957-018-1535-yUpregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinomaLei Shen0Chunhua Qian1Huimin Cao2Zhongrui Wang3Tingxian Luo4Chunli Liang5Department of Thyroid Breast Oncology, Shanghai East Hospital, School of Medicine, Tongji University School of MedicineDepartment of Endocrinolgy and Metabolism, Shanghai Tenth People’s Hospital, Tongji University School of MedicineDepartment of Thyroid and Breast, Shanghai Tenth People’s Hospital, Tongji University School of MedicineDepartment of Thyroid Breast Oncology, Shanghai East Hospital, School of Medicine, Tongji University School of MedicineDepartment of Thyroid Breast Oncology, Shanghai East Hospital, School of Medicine, Tongji University School of MedicineDepartment of Thyroid Breast Oncology, Shanghai East Hospital, School of Medicine, Tongji University School of MedicineAbstract Background The solute carrier (SLC) 7 family genes comprise 14 members and function as cationic amino acid/glycoprotein transporters in many cells, they are essential for the maintenance of amino acid nutrition and survival of tumor cells. This study was conducted to analyze the associations of SLC7 family gene expression with mortality in papillary thyroid carcinoma (PTC). Methods Clinical features, somatic mutations, and SLC7 family gene expression data were downloaded from The Cancer Genome Atlas database. Linear regression model analysis was performed to analyze the correlations between SLC7 family gene expression and clinicopathologic features. Kaplan-Meier survival and logistic regression analyses were performed to characterize the associations between gene expression and patients’ overall survival. Results Patient mortality was negatively associated with age and tumor size but positively increased cancer stage and absence of thyroiditis in PTC patients. Kaplan-Meier survival analysis indicated that patients with high SLC7A3, SLC7A5, and SLC7A11 expression levels exhibited poorer survival than those with low SLC7A3, SLC7A5, and SLC7A11 expression levels (P < 0.05 for all cases). Logistic regression analysis showed that SLC7A3, SLC7A5, and SLC7A11 were associated with increased mortality (odds ratio [OR] 8.61, 95% confidence interval [CI] 2.3–55.91; OR 3.87, 95% CI 1.18–17.31; and OR 3.87, 95% CI 1.18–17.31, respectively. Conclusion Upregulation of SLC7A3, SLC7A5, and SLC7A11 expression was associated with poor prognosis in PTC patients, and SLC7 gene expression levels are potentially useful prognostic biomarkers.http://link.springer.com/article/10.1186/s12957-018-1535-yPTCSLC7A3SLC7A5SLC7A11Overall survival
collection DOAJ
language English
format Article
sources DOAJ
author Lei Shen
Chunhua Qian
Huimin Cao
Zhongrui Wang
Tingxian Luo
Chunli Liang
spellingShingle Lei Shen
Chunhua Qian
Huimin Cao
Zhongrui Wang
Tingxian Luo
Chunli Liang
Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
World Journal of Surgical Oncology
PTC
SLC7A3
SLC7A5
SLC7A11
Overall survival
author_facet Lei Shen
Chunhua Qian
Huimin Cao
Zhongrui Wang
Tingxian Luo
Chunli Liang
author_sort Lei Shen
title Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
title_short Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
title_full Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
title_fullStr Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
title_full_unstemmed Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
title_sort upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
publisher BMC
series World Journal of Surgical Oncology
issn 1477-7819
publishDate 2018-12-01
description Abstract Background The solute carrier (SLC) 7 family genes comprise 14 members and function as cationic amino acid/glycoprotein transporters in many cells, they are essential for the maintenance of amino acid nutrition and survival of tumor cells. This study was conducted to analyze the associations of SLC7 family gene expression with mortality in papillary thyroid carcinoma (PTC). Methods Clinical features, somatic mutations, and SLC7 family gene expression data were downloaded from The Cancer Genome Atlas database. Linear regression model analysis was performed to analyze the correlations between SLC7 family gene expression and clinicopathologic features. Kaplan-Meier survival and logistic regression analyses were performed to characterize the associations between gene expression and patients’ overall survival. Results Patient mortality was negatively associated with age and tumor size but positively increased cancer stage and absence of thyroiditis in PTC patients. Kaplan-Meier survival analysis indicated that patients with high SLC7A3, SLC7A5, and SLC7A11 expression levels exhibited poorer survival than those with low SLC7A3, SLC7A5, and SLC7A11 expression levels (P < 0.05 for all cases). Logistic regression analysis showed that SLC7A3, SLC7A5, and SLC7A11 were associated with increased mortality (odds ratio [OR] 8.61, 95% confidence interval [CI] 2.3–55.91; OR 3.87, 95% CI 1.18–17.31; and OR 3.87, 95% CI 1.18–17.31, respectively. Conclusion Upregulation of SLC7A3, SLC7A5, and SLC7A11 expression was associated with poor prognosis in PTC patients, and SLC7 gene expression levels are potentially useful prognostic biomarkers.
topic PTC
SLC7A3
SLC7A5
SLC7A11
Overall survival
url http://link.springer.com/article/10.1186/s12957-018-1535-y
work_keys_str_mv AT leishen upregulationofthesolutecarrierfamily7genesisindicativeofpoorprognosisinpapillarythyroidcarcinoma
AT chunhuaqian upregulationofthesolutecarrierfamily7genesisindicativeofpoorprognosisinpapillarythyroidcarcinoma
AT huimincao upregulationofthesolutecarrierfamily7genesisindicativeofpoorprognosisinpapillarythyroidcarcinoma
AT zhongruiwang upregulationofthesolutecarrierfamily7genesisindicativeofpoorprognosisinpapillarythyroidcarcinoma
AT tingxianluo upregulationofthesolutecarrierfamily7genesisindicativeofpoorprognosisinpapillarythyroidcarcinoma
AT chunliliang upregulationofthesolutecarrierfamily7genesisindicativeofpoorprognosisinpapillarythyroidcarcinoma
_version_ 1724921505797636096